EcoDrugPlus

Ensembl ID : WBGene00222044
Gene Symbol: WBGENE00222044
6 External references
132 Possible Orthologues:

Ensembl ID : WBGene00222049
Gene Symbol: WBGENE00222049
4 External references
66 Possible Orthologues:

Ensembl ID : WBGene00222072
Gene Symbol: WBGENE00222072
4 External references
1159 Possible Orthologues:

Ensembl ID : WBGene00222077
Gene Symbol: WBGENE00222077
4 External references
214 Possible Orthologues:

Ensembl ID : WBGene00222105
Gene Symbol: WBGENE00222105
4 External references
78 Possible Orthologues:

Ensembl ID : WBGene00222128
Gene Symbol: WBGENE00222128
3 External references
170 Possible Orthologues:

Ensembl ID : WBGene00222157
Gene Symbol: WBGENE00222157
6 External references
129 Possible Orthologues:

Ensembl ID : WBGene00222214
Gene Symbol: WBGENE00222214
6 External references
95 Possible Orthologues:

Ensembl ID : WBGene00222233
Gene Symbol: WBGENE00222233
5 External references
23 Possible Orthologues:

Ensembl ID : WBGene00222284
Gene Symbol: WBGENE00222284
4 External references
88 Possible Orthologues:

Ensembl ID : WBGene00222295
Gene Symbol: WBGENE00222295
5 External references
1192 Possible Orthologues:

Ensembl ID : WBGene00220320
Gene Symbol: WBGENE00220320
3 External references
1193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).